Volume 2 | Issue 1 | DOI: https://doi.org/10.33696/haematology.2.023
Impact of Early COVID-19 Advice and Guidelines on the Blood Supply in Low- and Middle-Income Countries
- 1IQM Consulting, Zuidhorn, University of Groningen, Groningen, Netherlands
- 2Health City Hospital, Guwahati, Assam, India
- 3Rotary Bangalore ttk Blood Bank Bangalore, Karnataka, India
Cees Th. Smit Sibinga, firstname.lastname@example.org
Received Date: March 18, 2021
Accepted Date: April 02, 2021
Smit Sibinga CT, Choudhury N, Mathur A. Impact of Early COVID-19 Advice and Guidelines on the Blood Supply in Lowand Middle-Income Countries. J Clin Haematol. 2021; 2(1): 14-17.
Copyright: © 2021 Smit Sibinga CT, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Challenges, COVID-19, Blood supply, Clinical transfusion, Low-and middle-income countries, Blood donation, Stock management, Shortages
In silico Analysis for the Repurposing of Broad-spectrum Antiviral Drugs against Multiple Targets from SARS-CoV-2: A Molecular Docking and ADMET Approach
SARS-CoV-2 belongs to the genus Beta of the Coronaviridae family of enveloped single-stranded, positive-sense ribonucleic acid (RNA) with a genome length of 30,000bp. The virion is composed of various non-structural (RNA dependent RNA polymerase also known as RdRp) and structural proteins such as Spike (S), Nucleocapsid (N), Matrix (M), and Envelope (E) proteins.
This article is an extension to our recently published article in Asian Journal of Pharmaceutical and Clinical Research, entitled “Β-Sitosterol: Isolation from Muntingia Calabura Linn. Bark Extract, Structural Elucidation, and Molecular Docking Studies as Potential Inhibitor of SARSCoV-2 Mpro (COVID-19)”.
Rapid Inactivation of SARS-CoV-2 by Coupling Tungsten Trioxide (WO3) Photocatalyst with Copper Nanoclusters
At the end of 2019, a novel severe respiratory disease (coronavirus disease 2019, COVID-19) spread to Wuhan, China, it became pandemic in few months, with more than 41 million people infected worldwide as of October 2020. COVID-19 is caused by a novel virus called severe acute respiratory syndrome (SARS) CoV-2 to distinguish it from SARS-CoV that emerged in Guangdong province in China in 2003 and caused the severe clinical condition known as SARS. Like SARS-CoV, SARS- CoV-2 causes a severe inter
Quantifying Respiratory Airborne Particle Dispersion Control Through Improvised Reusable Masks: The Physics of Non-Pharmaceutical Interventions for Reducing SARS-CoV-2 (COVID-19) Airborne Transmission
In light of the current pandemic from rapid transmission of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2 or COVID-19) and significant morbidity, there has been inconsistent medical guidance given to the public regarding the wearing of non-medical improvised fabric masks or face coverings to reduce the transmission of COVID-19.
Severe acute respiratory syndrome coronavirus 2 (SARSCoV- 2) is a positive-sense, single-stranded RNA with genome size 26.2, and 31.7 kb coronavirus, covered by an enveloped structure, which is a major source of disaster in the 21st century. A typical CoV contains at least six ORFs in its genome. SARS-CoV-2 is the seventh coronavirus that is known to cause human disease.